Neuropsychiatry

Translational Neuropharmacology

Per Svenningsson_1_beskuren

Per Svenningsson
Professor

”   Parkinson´s disease and Depression are common disorders with largely unknown etiologies. There is a need for disease-modifying therapies in these disease states. The Section of Translational Neuropharmacology studies these disease states at a molecular and cellular level both in preclinical models and in specimens from patients. The goal is to identify novel targets for […] ”

+46 8 517 746 14
L8:01

Neurogenetics

Martin Schalling

Martin Schalling
Professor

” We focus on understanding how genes and environment contribute to development and treatment of psychiatric disorders such as depression, bipolar disease, schizophrenia and anorexia. We also focus on the anorectic state that is sometimes observed in end state renal disease, often in combination with cardiovascular complications and inflammation. Several projects are available in this area. […] ”

+46 8 517 744 81
L8:00

Bipolar disease - Schalling

Martin Schalling

Martin Schalling
Professor

” Affective disorders constitute major health problems with marked heritability. We aim to identify gene variants underlying susceptibility to bipolar disorder, seasonal affective disorder and various pain conditions. Large patient collections were created by use of Swedish registries and the public health care systems. Specifically we study polymorphisms and DNA sequence of gene pathways involved in […] ”

+46 8 517 744 81
L8:00

Lipidomics - Johansson

Dummyphoto

Björn Johansson
Associate Professor

” With whom do we cooperate? At CMM, Rachel Fisher, Göran Hansson, Magnus Nordenskjöld, Louise Nordfors, Lars Terenius, m.fl. Physicians in renal medicine and neurology at Karolinska Institutet/Universitetssjukhuset. Methods experts at the Technical Research Institute of Sweden and in Germany and Spain. What is the clinical relevance? Study of the lipid abnormalities of common chronic diseases […] ”

+46 8 524 870 71, +46 8 517 746 02
L8:00

Nephrogenetics - Nordfors

Louise_Nordfors

Louise Norsfors
Assistant Professor

” The prevalence of kidney disease is steadily increasing worldwide and in Sweden 1 in 20 suffers from severe renal insufficiency. The main aim of the Nephrogenetic project is to better understand the genetic basis for chronic kidney disease (CKD) and in particular its complications as this will help us develop better and individualized treatment strategies. […] ”

+46 8 517 755 41
L8:00

Eating disorders - Nilsson

Photo on 11-8-13 at 10.34 AM

Ida Nilsson
PhD

” The research of our team is focused on the Neurobiology eating disorders, in particular Anorexia Nervosa. Eating disorders are serious psychiatric disorders characterized by persistent problems concerning food intake, often combined with preoccupation about body weight and shape. Currently effective pharmacological or other biological target-directed therapy are lacking, in large due to the fact that […] ”

+46 8 517 746 02
L8:00, 014B

Schizophrenia - Ösby

Urban Ösby

Urban Ösby
MD

” We are studying metabolic, genetic and clinical aspects of psychosis in large Swedish cohorts that are followed prospectively. The use of state of the art epidemiological lab and genetic investigations are combined with studies of other cohorts (diabetes etc) to better understand the massive metabolic complications that accompany psychosis.   If you would like to […] ”

+46 8 524 823 16
L8:00

Depression - Lavebratt-Holmqvist

Catharina Lavebratt och Martin Schalling på CMM

Catharina Lavebratt-Holmqvist
Associate Professor

” Depression is common and an important cause of morbidity and mortality worldwide and a majority of the affected persons remain untreated. The one-year prevalence of depression is reported to be 5-10% and the incidence is increasing, especially in younger age groups. Both environment, such as negative life events and socioeconomic conditions, as well as heritable […] ”

+46 517 765 24
L8:00

CMM Research Groups

NEUROGENETICS AND PSYCHIATRIC DISEASES

GENETIC DISEASES

INFLAMMATORY DISEASES

Cardiovascular and Metabolic Diseases